(1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate

(1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate 구조식 이미지
카스 번호:
167271-60-5
상품명:
(1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate
동의어(영문):
7-APDA;(1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate;Imidazo( 1,2-B )Pyridazinum,1-[[(6R,7R)-7-Amino-2-Carboxy-8-Oxo-5-Thia-1-Azabicyclo(4,2,0)Oct-2-En-3-Yl]Methyl]-,Iodide;Imidazo[1,2-b]pyridazinium,1-[[(6R,7R)-7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,inner salt
CBNumber:
CB13069982
분자식:
C14H13N5O3S
포뮬러 무게:
331.35
MOL 파일:
167271-60-5.mol

(1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate 속성

안전

(1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate C화학적 특성, 용도, 생산

(1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate 준비 용품 및 원자재

원자재

준비 용품


(1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate 공급 업체

글로벌( 8)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21669 55
SIMAGCHEM CORP
+86-13806087780
sale@simagchem.com China 17367 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226
sales@hzclap.com CHINA 6313 58
AFINE CHEMICALS LIMITED
+86-0571-85134551
info@afinechem.com China 15395 58
GIHI CHEMICALS CO.,LIMITED
+8618058761490
info@gihichemicals.com China 49999 58
Mainchem Co., Ltd.
--
sarah@mainchem.com China 6572 58
Shanghai QianYan Bio-technology Co., Ltd 02781293128
orders@biochemsafebuy.com China 9934 55
Shaanxi DIDU pharmaceutical and Chemical Co., Ltd 15229059051
1027@dideu.com China 9968 58

Copyright 2019 © ChemicalBook. All rights reserved